Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
3.45M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
287K
-
Shares change
-
-21.4M
-
Total reported value, excl. options
-
$599K
-
Value change
-
-$19.5M
-
Number of sells
-
-28
-
Price
-
$2.09
Significant Holders of IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) as of Q2 2025
28 filings reported holding INAB - IN8BIO, INC. - Common Stock, $0.0001 par value per share as of Q2 2025.
IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 287K shares
of 3.45M outstanding shares and own 8.31% of the company stock.
Largest 10 shareholders include BIOS Capital Management, LP (287K shares), Chicago Partners Investment Group LLC (0 shares), Capital Investment Advisory Services, LLC (0 shares), Sigma Planning Corp (0 shares), Westside Investment Management, Inc. (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), AIGH Capital Management LLC (0 shares), SBI Securities Co., Ltd. (0 shares), VANGUARD GROUP INC (0 shares), and Stonegate Investment Group, LLC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.